CS logo
small CS logo
Kaleida Health/University of Buffalo

Buffalo, New York, United States
Medical center in Buffalo, New York
100 High St, Buffalo, NY 14203

About Kaleida Health/University of Buffalo


"Kaleida Health is the largest healthcare provider in Western New York, serving the area’s eight counties with state-of-the-art technology and comprehensive healthcare services. Its expert, compassionate healthcare professionals are committed to providing the best possible outcomes and experience for patients and visitors. More than one million sick or injured patients choose a Kaleida Health facility annually, including Bradford Regional Medical Center, Buffalo General Medical Center/Gates Vascular Institute, DeGraff Medical Park, Millard Fillmore Suburban Hospital, John R. Oishei Children’s Hospital and Olean General Hospital."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Actelion
2
Activ Surgical
1
Brigham and Women's Hospital
1
Medtronic Neurovascular Clinical Affairs
1
Standard Bariatrics
1
Total Rows: 5

Clinical Trials at Kaleida Health/University of Buffalo


During the past decade, Kaleida Health/University of Buffalo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200Started TrialsCompleted Trails20200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Therapy in Pulmonary Arterial Hypertension
2007-03-01
2010-08-01
Completed
100
Ventavis® Registry Protocol
2009-03-01
2014-02-01
Terminated
148
PRE-DETERMINE Cohort Study
2007-07-01
2026-11-01
Active, not recruiting
5,764
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
2014-07-24
2018-12-13
Completed
197
Multisite Study of Titan SGS Stapler in Longitudinal Gastric Resection
2020-07-02
2020-12-16
Completed
62
Safety and Feasibility of ActivSightTM in Human
2020-11-17
2024-01-01
Enrolling by invitation
40

Rows per page:

1–6 of 6

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kaleida Health/University of Buffalo" #1 sponsor was "Actelion" with 2 trials, followed by "Activ Surgical" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Medtronic Neurovascular Clinical Affairs" with 1 trials sponsored and "Standard Bariatrics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaleida Health/University of Buffalo" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Northwestern University" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Roche Diagnostics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Kaleida Health/University of Buffalo


According to Clinical.Site data, the most researched conditions in "Kaleida Health/University of Buffalo" are "Pulmonary Arterial Hypertension" (2 trials), "Acute Cholecystitis" (1 trials), "Colorectal Cancer" (1 trials), "Coronary Artery Disease" (1 trials) and "Diverticulitis, Colonic" (1 trials). Many other conditions were trialed in "Kaleida Health/University of Buffalo" in a lesser frequency.

Clinical Trials Intervention Types at Kaleida Health/University of Buffalo


Most popular intervention types in "Kaleida Health/University of Buffalo" are "Device" (3 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "ActivSight" (1 trials), "Bosentan" (1 trials), "Commercial Ventavis® (iloprost)" (1 trials), "Pipeline™ Embolization Device/ Pipeline™Flex Embolization Device" (1 trials) and "Sildenafil" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kaleida Health/University of Buffalo


The vast majority of trials in "Kaleida Health/University of Buffalo" are 6 trials for "All" genders.

Clinical Trials Status at Kaleida Health/University of Buffalo


Currently, there are NaN active trials in "Kaleida Health/University of Buffalo". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Kaleida Health/University of Buffalo, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kaleida Health/University of Buffalo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status